| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d75050b34f6de5ad249f4f0c9e7ed212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d861fac23f4f84303ca2470eed1481e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-715 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2008-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c270e6be8ca2e2f57c5f6fed44d9517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acf0e72b3b0d4467e63f65f75d7f2aa6 |
| publicationDate |
2009-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009053481-A1 |
| titleOfInvention |
Compositions and methods for modulating nk and t cell trafficking |
| abstract |
The present invention relates to methods of inhibiting the trafficking of NK cells and activated T cells, and for the prevention and/or treatment of inflammatory and autoimmune conditions. Generally, the present methods involve the use of agents that inhibit S1P5 in order to modulate the in vivo circulation of NK cells and activated T cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11479530-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017053990-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10995068-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8791100-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108366990-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10077236-B2 |
| priorityDate |
2007-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |